Загрузка...
Radium-223 and metastatic castration-resistant prostate cancer: All that glitters is not gold
After being approved by the National Drug Agency in several countries, Radium-223 (Ra-223) is gaining wide acceptance in the treatment of bone metastatic castration resistant prostate cancer. The exact mechanism of action remain unclear: The established model of direct alpha-particle irradiation fro...
Сохранить в:
| Опубликовано в: : | World J Radiol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Inc
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084059/ https://ncbi.nlm.nih.gov/pubmed/27843540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4329/wjr.v8.i10.816 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|